Cornerstone Capital Inc. Sells 3,855 Shares of AptarGroup, Inc. (NYSE:ATR)

Cornerstone Capital Inc. decreased its stake in AptarGroup, Inc. (NYSE:ATR - Free Report) by 3.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 124,105 shares of the industrial products company's stock after selling 3,855 shares during the quarter. AptarGroup accounts for about 1.9% of Cornerstone Capital Inc.'s investment portfolio, making the stock its 22nd largest holding. Cornerstone Capital Inc. owned 0.19% of AptarGroup worth $19,880,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Blue Trust Inc. raised its position in AptarGroup by 281.0% during the second quarter. Blue Trust Inc. now owns 240 shares of the industrial products company's stock valued at $35,000 after buying an additional 177 shares during the period. UMB Bank n.a. lifted its position in shares of AptarGroup by 446.5% in the third quarter. UMB Bank n.a. now owns 235 shares of the industrial products company's stock worth $38,000 after purchasing an additional 192 shares in the last quarter. Gradient Investments LLC acquired a new stake in shares of AptarGroup during the second quarter worth approximately $40,000. Versant Capital Management Inc grew its position in AptarGroup by 4,983.3% during the second quarter. Versant Capital Management Inc now owns 305 shares of the industrial products company's stock valued at $43,000 after purchasing an additional 299 shares in the last quarter. Finally, Adirondack Trust Co. increased its stake in AptarGroup by 25.0% in the 2nd quarter. Adirondack Trust Co. now owns 500 shares of the industrial products company's stock valued at $70,000 after buying an additional 100 shares during the period. Hedge funds and other institutional investors own 88.52% of the company's stock.

AptarGroup Stock Performance

NYSE ATR traded up $2.05 during trading on Tuesday, hitting $170.31. The company's stock had a trading volume of 206,150 shares, compared to its average volume of 292,279. AptarGroup, Inc. has a 52 week low of $122.29 and a 52 week high of $171.41. The firm has a market cap of $11.33 billion, a P/E ratio of 33.79, a price-to-earnings-growth ratio of 2.91 and a beta of 0.57. The firm has a 50 day moving average price of $159.30 and a 200 day moving average price of $150.33. The company has a quick ratio of 1.15, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

AptarGroup Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 14th. Stockholders of record on Thursday, October 24th will be issued a dividend of $0.45 per share. The ex-dividend date is Thursday, October 24th. This represents a $1.80 annualized dividend and a dividend yield of 1.06%. AptarGroup's payout ratio is 36.14%.

AptarGroup announced that its Board of Directors has authorized a share buyback plan on Thursday, October 10th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the industrial products company to purchase up to 4.7% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board believes its stock is undervalued.

Analyst Ratings Changes

Several equities analysts have recently commented on ATR shares. Robert W. Baird boosted their price target on shares of AptarGroup from $170.00 to $185.00 and gave the company an "outperform" rating in a report on Monday, October 28th. Jefferies Financial Group upgraded AptarGroup from a "hold" rating to a "buy" rating and raised their target price for the company from $155.00 to $215.00 in a report on Monday, October 14th. Dbs Bank raised AptarGroup from a "hold" rating to a "strong-buy" rating in a report on Wednesday, October 16th. Finally, Wells Fargo & Company boosted their target price on AptarGroup from $168.00 to $185.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $195.00.

Insider Activity

In other news, CEO Stephan B. Tanda sold 30,000 shares of AptarGroup stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $169.60, for a total transaction of $5,088,000.00. Following the sale, the chief executive officer now owns 174,118 shares of the company's stock, valued at approximately $29,530,412.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Hedi Tlili sold 1,375 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $152.54, for a total value of $209,742.50. Following the completion of the transaction, the insider now directly owns 9,379 shares of the company's stock, valued at approximately $1,430,672.66. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Stephan B. Tanda sold 30,000 shares of the business's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $169.60, for a total value of $5,088,000.00. Following the completion of the sale, the chief executive officer now directly owns 174,118 shares in the company, valued at approximately $29,530,412.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 47,457 shares of company stock valued at $7,680,110. Insiders own 1.00% of the company's stock.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.